Dr Jinzi Jason has been appointed VP research of PhageTech Inc, a Montreal-based developer of antibiotic drugs based on proprietary phage genomics (bacterial viruses). Jason has considerable expertise in small molecule drugs discovery, with previous experience at Immunex, Novartis and Aventis. He holds an MD from Nanjing Univ’s school of medicine and a PhD in cancer biology from the Univ of Tucson….
Vent